E‐cadherin—catenin cell—cell adhesion complex and human cancer

The E‐cadherin–catenin complex plays a crucial role in epithelial cell–cell adhesion and in the maintenance of tissue architecture. Perturbation in the expression or function of this complex results in loss of intercellular adhesion, with possible consequent cell transformation and tumour progression. Recently, much progress has been made in understanding the interaction between the different components of this protein complex and how this cell–cell adhesion complex is modulated in cancer cells.

[1]  H. Clevers,et al.  The Yin-Yang of TCF/beta-catenin signaling. , 2000, Advances in cancer research.

[2]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[3]  M. Monden,et al.  E‐cadherin mediated adhesion system in cancer cells , 1996, Cancer.

[4]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[5]  W. Jiang,et al.  Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. , 1999, Biochemical and biophysical research communications.

[6]  A. Nagafuchi,et al.  Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. , 1997, Cancer research.

[7]  Y. Doki,et al.  Characterization of soluble E-cadherin as a disease marker in gastric cancer patients. , 1998, British Journal of Cancer.

[8]  P. Matarrese,et al.  Antiproliferative activity of interferon α and retinoic acid in SiHa carcinoma cells: The role of cell adhesion , 1998, International journal of cancer.

[9]  M. Bertagnolli,et al.  Aspirin prevents tumors in a murine model of familial adenomatous polyposis. , 1998, Surgery.

[10]  M J Wheelock,et al.  Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin , 1992, The Journal of cell biology.

[11]  G Brabant,et al.  Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. , 1997, Cancer research.

[12]  M. Takeichi,et al.  Unstable Expression of E‐Cadherin Adhesion Molecules in Metastatic Ovarian Tumor Cells , 1989, Japanese journal of cancer research : Gann.

[13]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[14]  A. Kinsella,et al.  Cadherin–catenin expression in primary colorectal cancer: a survival analysis , 1999, British Journal of Cancer.

[15]  M. Pignatelli,et al.  The molecular histology of neoplasia: the role of the cadherin/catenin complex , 1997, Histopathology.

[16]  Boecker,et al.  Immunophenotypic and prognostic analysis of E‐cadherin and β‐catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44 , 1999, Histopathology.

[17]  V. Álvarez,et al.  Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neck. , 1998, Journal of clinical pathology.

[18]  Frank Speleman,et al.  The αE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells , 1999, Oncogene.

[19]  Takuma Sasaki,et al.  E‐cadherin and urokinase‐type plasminogen activator tissue status in gastric carcinoma , 1995, Cancer.

[20]  J Mao,et al.  Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt‐mediated regulation of LEF‐1 , 1999, The EMBO journal.

[21]  S. Hirohashi,et al.  A Truncated β-Catenin Disrupts the Interaction between E-Cadherin and α-Catenin: A Cause of Loss of Intercellular Adhesiveness in Human Cancer Cell Lines , 1994 .

[22]  J. Jankowski,et al.  Changes in gene structure and regulation of E-cadherin during epithelial development, differentiation, and disease. , 1997, Progress in nucleic acid research and molecular biology.

[23]  Gerhard Christofori,et al.  A causal role for E-cadherin in the transition from adenoma to carcinoma , 1998, Nature.

[24]  W. Birchmeier,et al.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.

[25]  J. Gordon,et al.  Inflammatory Bowel Disease and Adenomas in Mice Expressing a Dominant Negative N-Cadherin , 1995, Science.

[26]  Y. Doki,et al.  Expression of E-Cadherin and α-Catenin in Patients with Colorectal Carcinoma: Correlation with Cancer Invasion and Metastasis , 1999 .

[27]  M. Menger,et al.  Adhesion molecules as determinants of disease: From molecular biology to surgical research , 1996, The British journal of surgery.

[28]  C. Soler,et al.  Cadherin mediated cell-cell adhesion is regulated by tyrosine phosphatases in human keratinocytes. , 1998, Cell adhesion and communication.

[29]  K. Syrigos,et al.  Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. , 1998, Anticancer research.

[30]  H. Terpe,et al.  CD44s, E-cadherin and PCNA as markers for progression in renal cell carcinoma. , 1999, Anticancer research.

[31]  W. Birchmeier,et al.  Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion , 1989, The Journal of cell biology.

[32]  A. Kikuchi,et al.  Roles of Axin in the Wnt signalling pathway. , 1999, Cellular signalling.

[33]  L. Ellis,et al.  Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  W. Birchmeier,et al.  Adherens junction proteins in tumour progression. , 1995, Cancer surveys.

[35]  B. Gumbiner,et al.  Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus , 1996, The Journal of cell biology.

[36]  J. Schalken,et al.  Decreased expression of α‐catenin is associated with poor prognosis of patients with localized renal cell carcinoma , 1997 .

[37]  M. Farthing,et al.  Abnormal expression and function of the E-cadherin–catenin complex in gastric carcinoma cell lines , 1999, British Journal of Cancer.

[38]  B. Herrmann,et al.  Nuclear localization of β-catenin by interaction with transcription factor LEF-1 , 1996, Mechanisms of Development.

[39]  M. Polette,et al.  Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. , 1998, The American journal of pathology.

[40]  T. Tamaya,et al.  Progestins and danazol effect on cell-to-cell adhesion, and E-cadherin and α- and β-catenin mRNA expressions , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[41]  A. Mercurio,et al.  Poorly differentiated colon carcinoma cell lines deficient in alpha-catenin expression express high levels of surface E-cadherin but lack Ca(2+)-dependent cell-cell adhesion. , 1993, Cell adhesion and communication.

[42]  B. Sanson,et al.  Uncoupling cadherin-based adhesion from wingless signalling in Drosophila , 1996, Nature.

[43]  D. Rimm,et al.  Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. , 1999, Cancer research.

[44]  Y. Doki,et al.  Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line. , 1995, British Journal of Cancer.

[45]  H. Höfler,et al.  Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. , 1999, The American journal of pathology.

[46]  Y. Doki,et al.  Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer. , 1998, British Journal of Cancer.

[47]  P. Bonnier,et al.  Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival. , 1998, American journal of clinical pathology.

[48]  W. Hop,et al.  Reduced expression of the cadherin–catenin complex in oesophageal adenocarcinoma correlates with poor prognosis , 1997, The Journal of pathology.

[49]  Janusz Jankowski,et al.  Sequential changes in cadherin‐catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma , 1998 .

[50]  W F Bodmer,et al.  Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  T. Yoneda,et al.  E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. , 1996, Cancer research.

[52]  D. Rimm,et al.  Loss of p120ctn in human colorectal cancer predicts metastasis and poor survival. , 1998, Cancer letters.

[53]  M. Farthing,et al.  Up‐regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120ctn in gastric carcinoma , 1999, The Journal of pathology.

[54]  A. Børresen-Dale,et al.  Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas , 1997, Virchows Archiv.

[55]  G. Berx,et al.  E‐cadherin gene alterations are rare events in thyroid tumors , 1997, International journal of cancer.

[56]  Paul Polakis,et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors , 1999, Oncogene.

[57]  D. Evans,et al.  Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. , 1999, Human molecular genetics.

[58]  N. Lemoine,et al.  Characterization of the E‐cadherin–catenin complexes in pancreatic carcinoma cell lines , 1999, The Journal of pathology.

[59]  H. Höfler,et al.  Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterations , 1999, Virchows Archiv.

[60]  M. Takeichi,et al.  p120ctn Acts as an Inhibitory Regulator of Cadherin Function in Colon Carcinoma Cells , 1999, The Journal of cell biology.

[61]  S. Jordan,et al.  Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. , 1997, Gastroenterology.

[62]  L. Billingham,et al.  Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance. , 1997, Journal of clinical pathology.

[63]  M. Takeichi,et al.  Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts , 1992, The Journal of cell biology.

[64]  M. J. van de Vijver,et al.  Simultaneous loss of E‐cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ , 1997, The Journal of pathology.

[65]  A. Scarpa,et al.  Pancreatic carcinoma , 1998, Cancer.

[66]  P. Vogt,et al.  Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  M. Hamaguchi,et al.  Tyrosine phosphorylation of 100-130 kDa proteins in lung cancer correlates with poor prognosis. , 1996, British Journal of Cancer.

[68]  S. Hirohashi,et al.  E‐Cadherin Gene Mutations in Signet Ring Cell Carcinoma of the Stomach , 1996, Japanese journal of cancer research : Gann.

[69]  M. Duffy,et al.  Assay of E-cadherin by ELISA in human breast cancers. , 1997, European journal of cancer.

[70]  W. Dinjens,et al.  E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus , 1999, British Journal of Cancer.

[71]  A. Forbes,et al.  Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers. , 1997, Journal of clinical pathology.

[72]  M. Mareel,et al.  Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. , 1994, Cancer research.

[73]  H Clevers,et al.  TCF/LEF factor earn their wings. , 1997, Trends in genetics : TIG.

[74]  J. Epstein,et al.  E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens. , 1999, Urology.

[75]  J. Schalken,et al.  Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. , 1996, Cancer research.

[76]  P. McCrea,et al.  E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. , 1996, Cancer research.

[77]  N. Shepherd,et al.  Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. , 1997, Molecular pathology : MP.

[78]  N. Sato,et al.  Interaction of the Sarcin/Ricin Domain of 23 S Ribosomal RNA with Proteins L3 and L6* , 1999, The Journal of Biological Chemistry.

[79]  W. Hohenberger,et al.  Predictive value of nuclear betacatenin expression for the occurrence of distant metastases in rectal cancer , 1998, Diseases of the colon and rectum.

[80]  Y. Nakamura,et al.  Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. , 1998, Cancer research.

[81]  D. O’Toole,et al.  H pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control. , 1998, Journal of clinical pathology.

[82]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[83]  P. McCrea,et al.  Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[84]  J. Schalken,et al.  Mechanisms associated with abnormal E‐cadherin immunoreactivity in human bladder tumors , 1999, International journal of cancer.

[85]  M. Takeichi,et al.  Cell binding function of E‐cadherin is regulated by the cytoplasmic domain. , 1988, The EMBO journal.

[86]  D. Neal,et al.  Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence. , 1996, British Journal of Cancer.

[87]  D. Riethmacher,et al.  A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[88]  M. Takeichi,et al.  Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line , 1994, The Journal of cell biology.

[89]  E. Surmacz,et al.  Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. , 1997, Experimental cell research.

[90]  V. Kosma,et al.  Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma. , 1999, Journal of clinical pathology.

[91]  Frans,et al.  Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene , 1993, The Journal of cell biology.

[92]  C W Turck,et al.  A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. , 1991, Science.

[93]  I. El-Hariry,et al.  Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps. , 1997, The American journal of pathology.

[94]  W. Birchmeier,et al.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.

[95]  P. Polakis,et al.  Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes , 1996, Molecular and cellular biology.

[96]  M. J. van de Vijver,et al.  © 1997 Cancer Research Campaign , 2022 .

[97]  W. Nelson,et al.  Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. , 1997, Current opinion in cell biology.

[98]  Y. Niitsu,et al.  Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39 , 1995, Molecular and cellular biology.

[99]  S. Hiscox,et al.  Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer. , 1997, Anticancer research.

[100]  G. Berx,et al.  E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. , 1996, Oncogene.

[101]  K. Miyazawa,et al.  Association of p120, a tyrosine kinase substrate, with E- cadherin/catenin complexes , 1995, The Journal of cell biology.

[102]  F. van Roy,et al.  Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. , 1999, Cancer research.

[103]  J. Herman,et al.  E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. , 1995, Cancer research.

[104]  G. Cowley,et al.  Modulation of E‐cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas , 2006, International journal of cancer.

[105]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[106]  Peter D. Kwong,et al.  Structural basis of cell-cell adhesion by cadherins , 1995, Nature.

[107]  Bert Vogelstein,et al.  Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer , 1998 .

[108]  A. Watanabe,et al.  Clinicopathologic evaluation of immunohistochemical E‐cadherin expression in human gastric carcinomas , 1995, Cancer.

[109]  A. Ochiai,et al.  Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. , 1996, Cancer research.

[110]  N. Lemoine,et al.  Loss of membranous E‐cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage , 1994, The Journal of pathology.

[111]  Robert S. Kerbel,et al.  E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1 , 1998, The Journal of cell biology.

[112]  Mellon,et al.  The impact of transurethral resection of bladder tumour on serum levels of soluble E‐cadherin , 1999, BJU international.

[113]  Katsuo Suzuki,et al.  Loss of density‐dependent growth inhibition and dissociation of α‐catenin from E‐cadherin , 1997 .

[114]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[115]  W. Birchmeier,et al.  Prognostic value of E‐cadherin expression in 413 gastric carcinomas , 1996, International journal of cancer.

[116]  M. Mareel,et al.  Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid. , 1995, British Journal of Cancer.

[117]  G. Berx,et al.  E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[118]  J. Gordon,et al.  Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. , 1996, Genes & development.

[119]  A. Raz,et al.  Improved prognosis assessment for patients with bladder carcinoma. , 1997, The American journal of pathology.

[120]  V. Kosma,et al.  α-Catenin expression has prognostic value in local and locally advanced prostate cancer , 1999, British Journal of Cancer.

[121]  A. Franchi,et al.  Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[122]  Z. Kam,et al.  p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry , 1999, Oncogene.

[123]  S. Hirohashi,et al.  The E‐cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas , 1997, International journal of cancer.

[124]  W. Birchmeier,et al.  Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. , 1995, Oncogene.

[125]  G. Stamp,et al.  Relevance of risk assessment to exposed communities. , 1995, Environmental health perspectives.

[126]  M. Pignatelli,et al.  Catenins and their associated proteins in colorectal cancer. , 2000, Histology and histopathology.

[127]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[128]  A. Børresen-Dale,et al.  E‐cadherin and α‐, β‐, and γ‐catenin protein expression in relation to metastasis in human breast carcinoma , 1998 .

[129]  D. Rimm,et al.  Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. , 1999, The American journal of pathology.

[130]  J. Taylor‐Papadimitriou,et al.  Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[131]  J. Daniel,et al.  Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes , 1994, Molecular and cellular biology.

[132]  T. Terada,et al.  Expression of e‐cadherin, α‐catenin, β‐catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: An immunohistochemical study , 1998 .

[133]  F. Lottspeich,et al.  The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[134]  K. Miyazawa,et al.  Tyrosine Phosphorylation of β-Catenin and Plakoglobin Enhanced by Hepatocyte Growth Factor and Epidermal Growth Factor in Human Carcinoma Cells , 1994 .

[135]  W. Fiers,et al.  Down‐regulation of E‐cadherin expression in madin darby canine kidney (MDCK) cells inside tumors of nude mice , 1991, International journal of cancer.

[136]  A. Skoudy,et al.  P120‐catenin expression in human colorectal cancer , 1996 .

[137]  Elaine Fuchs,et al.  A common human skin tumour is caused by activating mutations in β-catenin , 1999, Nature Genetics.

[138]  T Ochi,et al.  Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. , 1998, Oncology research.

[139]  H. Barr,et al.  Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. , 1998, The American journal of pathology.

[140]  R. Nusse,et al.  Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex. , 1999, Genes & development.

[141]  L. Trusolino,et al.  Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. , 1996, Journal of the National Cancer Institute.

[142]  E. Gelmann,et al.  β-Catenin Mutations in Human Prostate Cancer , 1998 .

[143]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[144]  Heinz Höfler,et al.  Mutations of the human E‐cadherin (CDH1) gene , 1998, Human mutation.

[145]  S. Komiyama,et al.  All‐trans‐retinoic Acid‐dependent Inhibition of E‐Cadherin‐based Cell Adhesion with Concomitant Dephosphorylation of β‐Catenin in Metastatic Human Renal Carcinoma Cells , 1997, Japanese journal of cancer research : Gann.

[146]  S. Byers,et al.  Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: measurement of cell-cell adhesion strength. , 1995, Journal of cell science.

[147]  Tytgat,et al.  Loss of E‐cadherin expression in early gastric cancer , 1999, Histopathology.

[148]  T. Helliwell,et al.  Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. , 1997, British Journal of Cancer.

[149]  S. Hirohashi,et al.  Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[150]  M. Monden,et al.  Decreased E‐cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus , 1996, The British journal of surgery.

[151]  D L Rimm,et al.  Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.